🇺🇸 FDA
Patent

US 9512125

Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents

granted A61PA61P1/00A61P1/02

Quick answer

US patent 9512125 (Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents) held by The Regents of the University of California expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P11/00